Abschluss eines nicht exklusiven Rabattvertrages nach§ 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Midazolam (ATC-Code: N03AE02) innerhalb des Zeitraumes vom 01.12.2026 bis zum 30.11.2028 mit jederzeitiger Möglichkeit des Vertragsabschlusses während der Laufzeit („open-house-Modell“).

TENDER DESCRIPTION

For the active ingredient Midazolam (ATC code: N03AE02), AOK Niedersachsen provides it. For the period until the entry into force of exclusive contracts as a result of a formal award procedure in accordance with the rules of Part 4 of the GWB, AOK Niedersachsen offers, without any selection decision, rebate contracts to all interested pharmaceutical companies. Contract award takes place within the framework of an “open-house model” and serves as a bridge between the start of generic competition (expiry of the patent) and the award of exclusive contracts. The contracts offered are non-exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Niedersachsen. Under the open-house model, uniform conditions apply to all participants. Contract content, terms and conditions and access procedures are uniform—individual negotiations are generally not conducted. The contract terms are a maximum of twenty-four months; the earliest contract start date is 01.12.2026. All contracts end no later than 30.11.2028, irrespective of the date of the respective contract award. Accession or contract award within the twenty-four-month period may be made each time on…

TENDER BRIEF

TENDER DOCUMENTS